跳至主要内容
临床试验/NCT01268592
NCT01268592终止不适用

Vitrification of Oocytes From Female Cancer Patients to Preserve Their Fertility Potential

Northwell Health1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2010年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
16
试验地点
1
主要终点
successful pregnancy

研究概览

简要总结

The purpose of this study is to preserve the fertility potential in females diagnosed with cancer by vitrifying (rapidly freezing) their oocytes (eggs) before undergoing treatment for their cancer.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
14 Years 至 42 Years(Child, Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •Patients must be 14-42 year old females with a cancer diagnosis.
  • •Clearance letter from treating oncologist.
  • •Approval by program oncologist or her designee.
  • •Informed consent has to be signed after consultation with the program physician. Minors require consent of a parent or a legal guardian and assent from the participant.
  • •Life expectancy (predicted by their malignancy) of 5 or more years.
  • •Cancer diagnosis should have an expected cure rate of 50% or more, based upon clinico-pathologic features.

排除标准

  • •Patients whose oncologist and the program oncologist concur that immediate oncologic care should be rendered, not allowing sufficient time for a course of gonadotropin therapy and egg retrieval.
  • •FSH level >20 MIU/ml, indicating abnormal ovarian function.
  • •Patients with stage IV cancers (*age appropriate women with stage IV advanced Hodgkin's Lymphoma will be considered, as there is a significant long term survival rate with this advanced disease).
  • •Patients with incurable cancer diagnoses.
  • •Patients who are unable or unwilling to sign the informed consent.
  • •Women cannot have an embryo transfer beyond age 50.

研究组 & 干预措施

positive cancer diagnosis

Experimental

female patients diagnosed with cancer who wish to preserve their fertility by vitrifying their oocytes

干预措施: oocyte vitrification (Procedure)

结局指标

主要结局

successful pregnancy

时间窗: nine months after transfer of embryo(s)

the primary objective of this study is the establishment of a successful pregnancy, following a disease-free interval after treatment for her cancer; this interval will be patient-dependent and will undoubtedly vary between participants.

次要结局

  • impact of stimulation on cancer recurrence(5 years after treatment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Fertility Preservation in Female Cancer Patients | 临床试验